Printer Friendly

Articles from Dermatology News (June 1, 2020)

1-49 out of 49 article(s)
Title Author Type Words
AAD offers guidance for resuming nonessential patient visits. Gallegos, Alicia 532
Acne before puberty: When to treat, when to worry. Dotinga, Randy 1037
Anti-Ro52 autoantibodies signal interstitial lung disease. Jancin, Bruce 737
Audrey Hepburn's lessons for a COVID clinic. Benabio, Jeffrey 653
Belimumab may improve skin disease, pilot study finds. Jancin, Bruce 800
Cancer drug shows benefits in treating anal lesions. Otto, M. Alexander 607
Case reports illustrate heterogeneity of skin manifestations in patients with COVID-19 infection. Bosworth, Ted 1063
COVID fatigue is setting in. Coldiron, Brett M. 726
COVID-19 decimating outpatient office visits. Ault, Alicia 390
Dermatologic changes with COVID-19: What we know and don't know. 3232
Dermatologic treatments can be complementary. Sidbury, Robert; Eichenfield, Lawrence F. 510
Destress dermatologic procedures with honesty, distraction, and relaxation. Splete, Heidi 524
Early onset of AD linked to poorer control. Nogrady, Bianca 753
Energy-based therapy plus oxymetazoline improved erythema. Rans, Caleb 367
EU panel supports decision to pull topical AK therapy from market. Brooks, Megan 239
Evidence on spironolactone safety reassuring. Otto, M. Alexander 828
Fast, aggressive eczema treatment linked to fewer food allergies by age 2 years. Smith, Jennie 514
FDA approves pomalidomide for Kaposi sarcoma. Mulcahy, Nick 374
Frequent soaks ease pediatric atopic dermatitis. Splete, Heidi 559
Kawasaki disease. Cusick, Elizabeth H.; Plovanich, Molly E. 625
Laser surgery precautions as clinics begin to reopen. Wesley, Naissan O.; Talakoub, Lily 1108
Low-income D.C. residents have less access to iPLEDGE. Brunk, Doug 522
MERKEL CELL PROGRESS: Management undergoes a revolution. Jancin, Bruce 1418
More screening for depression recommended. Jancin, Bruce 999
Most epidermolysis bullosa patients turn to topical antimicrobials. Splete, Heidi 423
Multiple therapies in advanced-stage development. Jancin, Bruce 1581
Neoadjuvant nivolumab 'promising' for high-risk disease. Nelson, Roxanne Clinical report 861
Neutrophilic eccrine hidradenitis attributed to HIV treatment. Jancin, Bruce 370
New cantharidin formulation alleviates molluscum contagiosum in pivotal trials. Greb, Erik 541
New mechanisms, therapies for acne considered. Kling, Jim 1023
New topicals coming for pediatric atopic dermatitis. Jancin, Bruce 785
Omalizumab proves effective for treating patients with severe pediatric atopic dermatitis. Cimino, Steve 698
Overhead management during a crisis. Eastern, Joseph S. 775
Pandemic spurs telemedicine, furloughs, retirement. Twachtman, Gregory 733
Patch testing in atopic dermatitis: When and how. Jancin, Bruce 1075
Patients with AD should routinely be asked about conjunctivitis. Craven, Jeff 896
Potential applications include collagen vascular diseases. Brunk, Doug 872
Practicing in a pandemic. Rockoff, Alan 794
PRACTICING IN A PANDEMIC: Slow, steady approach recommended to reopening laser, cosmetic surgery offices. Brunk, Doug 1869
Psychology consult for children's skin issues can boost adherence, wellness. Brunk, Doug 1225
Review looks at alopecia areata's natural course. Remaly, Jake 962
Sensitizer prevalent in many hypoallergenic products for children. Palmer, Christopher 322
Sericin: Multiple potential roles in dermatology. Baumann, Leslie S. 1582
Sun-damage selfies give kids motivation to protect skin. Dotinga, Randy 779
Topical calcineurin inhibitors are effective treatment option for periorificial dermatitis. Brunk, Doug 834
Topical clascoterone now under review at the FDA. Jancin, Bruce 386
Use of mHealth technology lags in lupus care, research. Evans, Jeff 381
When to suspect it and what to do about it. Jancin, Bruce 829
Which children are at greatest risk for AD? Jancin, Bruce 807

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters